FDA Inspection 1321470 — Vaibhav Daulat Pandharkar, MBBS
The FDA completed an inspection of Vaibhav Daulat Pandharkar, MBBS on May 15, 2026 in Pune. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 15, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pune (India)
Additional Details
Clinical BA/BE